These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3531024)

  • 21. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial.
    Talan DA; Stamm WE; Hooton TM; Moran GJ; Burke T; Iravani A; Reuning-Scherer J; Church DA
    JAMA; 2000 Mar 22-29; 283(12):1583-90. PubMed ID: 10735395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Norfloxacin versus trimethoprim-sulphamethoxazole: efficacy in a model of ascending urinary tract infection in normal and streptozotocin-induced diabetic mice.
    Fromtling RA; Abruzzo GK; Gilfillan EC; Pelak BA; Gadebusch HH
    J Antimicrob Chemother; 1985 Dec; 16(6):735-41. PubMed ID: 3912365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in Bacterial Resistance Patterns of Pediatric Urinary Tract Infections and Rationale for Empirical Antibiotic Therapy.
    Gökçe İ; Çiçek N; Güven S; Altuntaş Ü; Bıyıklı N; Yıldız N; Alpay H
    Balkan Med J; 2017 Sep; 34(5):432-435. PubMed ID: 28443576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of co-trimoxazole in sulphonamide-resistant Escherichia coli urinary tract infection.
    Grüneberg RN
    J Antimicrob Chemother; 1975 Sep; 1(3):305-10. PubMed ID: 1102516
    [No Abstract]   [Full Text] [Related]  

  • 25. An assessment of amoxycillin versus co-trimoxazole in respiratory tract infections.
    Sharma NG
    Indian J Chest Dis Allied Sci; 1984; 26(4):230-3. PubMed ID: 6400092
    [No Abstract]   [Full Text] [Related]  

  • 26. Ciprofloxacin treatment of urinary infections results in increased resistance of urinary E. coli to ciprofloxacin and co-trimoxazole.
    Borgmann S; Jakobiak T; Gruber H; Schröder H; Sagel U
    Pol J Microbiol; 2009; 58(4):371-3. PubMed ID: 20380149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-trimoxazole versus nafcillin in the therapy of experimental meningitis due to Staphylococcus aureus.
    Scheld WM; Keeley JM; Field MR; Brodeur JP
    J Antimicrob Chemother; 1987 May; 19(5):647-58. PubMed ID: 3497147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-dose therapy for cystitis in women. A comparison of trimethoprim-sulfamethoxazole, amoxicillin, and cyclacillin.
    Hooton TM; Running K; Stamm WE
    JAMA; 1985 Jan; 253(3):387-90. PubMed ID: 3871233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of trimethoprim/sulfamethoxazole in experimental Escherichia coli bacteremia and meningitis.
    Kim KS; Anthony BF
    Chemotherapy; 1983; 29(6):428-35. PubMed ID: 6360577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial.
    Ericsson CD; Johnson PC; Dupont HL; Morgan DR; Bitsura JA; de la Cabada FJ
    Ann Intern Med; 1987 Feb; 106(2):216-20. PubMed ID: 3541724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between phylogenetic groups, antibiotic resistance and patient characteristics in terms of adhesin genes in cystitis and pyelonephritis isolates of Escherichia coli.
    Er DK; Dundar D; Uzuner H; Osmani A
    Microb Pathog; 2015 Dec; 89():188-94. PubMed ID: 26518125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative activities of ciprofloxacin, amoxicillin, and cotrimoxazole in an experimental model of enteritis caused by Salmonella non typhi].
    Gómez-Garcés JL; Castilla C
    Enferm Infecc Microbiol Clin; 1992; 10(7):389-92. PubMed ID: 1450256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of augmentin with co-trimoxazole for treatment of uncomplicated urinary tract infections.
    Bailey RR; Bishop V; Peddie B; Chambers PF; Davies PR; Crofts HG
    N Z Med J; 1983 Nov; 96(744):970-2. PubMed ID: 6605501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model.
    Vellinga A; Tansey S; Hanahoe B; Bennett K; Murphy AW; Cormican M
    J Antimicrob Chemother; 2012 Oct; 67(10):2523-30. PubMed ID: 22729920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-dose ceftriaxone treatment of urinary tract infections.
    Rosenberg JM; Levy RC; Cicmanec JF; Hedges JR; Burke BM
    Ann Emerg Med; 1985 Oct; 14(10):970-2. PubMed ID: 3898930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current antibiotic resistance profile of uropathogenic Escherichia coli strains and therapeutic consequences].
    El Bouamri MC; Arsalane L; Kamouni Y; Yahyaoui H; Bennouar N; Berraha M; Zouhair S
    Prog Urol; 2014 Dec; 24(16):1058-62. PubMed ID: 25310915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of recent antibacterial agents against bacteria causing diarrhoea.
    Bergan T; Lolekha S; Cheong MK; Poh CL; Doencham S; Charoenpipop D
    Scand J Infect Dis Suppl; 1988; 56():7-10. PubMed ID: 3266900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of cefixime and co-trimoxazole in acute uncomplicated urinary tract infection. A double-blind general practice study.
    Levenstein J; Summerfield PJ; Fourie S; Brink G; Michaelides B; Murray E; Naidoo N
    S Afr Med J; 1986 Oct; 70(8):455-60. PubMed ID: 3535127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multilevel analysis of trimethoprim and ciprofloxacin prescribing and resistance of uropathogenic Escherichia coli in general practice.
    Vellinga A; Murphy AW; Hanahoe B; Bennett K; Cormican M
    J Antimicrob Chemother; 2010 Jul; 65(7):1514-20. PubMed ID: 20457673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Cohort Study of Risk Factors That Influence Empirical Treatment of Patients with Acute Pyelonephritis.
    Bosch-Nicolau P; Falcó V; Viñado B; Andreu A; Len O; Almirante B; Pigrau C
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.